42: Biosimilars; What, How, When?

Please join your host, Justin Baker, as he learns from industry experts, Connor Nell and Brian Biehn, why biosimilars are becoming such an eye-opening opportunity, and why independents need to take a hard look at them.

In addition to being an alternative to expensive brand name drugs, the breadth of biosimilars is growing exponentially, and gaining acceptance with physicians, pharmacists and patients. 

This countertop chat dives deeply into increasing access, understanding their benefits, and gaining confidence in these emerging therapies.